Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rory Wolfe

Showing results (401-410 of 424) with videos related to

Pageof 43
Sort By:
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
Sleep|September 20, 2024
Obstructive sleep apnea and cerebral small vessel disease in community-based older people: an aspirin in reducing events in the elderly imaging substudyStephanie A Ward, Elsdon Storey, Matthew T Naughton, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trialSophia Zoungas, David D'Alessio, Imre Pavo, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Pageof 43

Showing results (401-410 of 424) with videos related to

Sort By:
Pageof 43
The Lancet. Healthy Longevity|October 3, 2025
Aspirin and healthy lifespan in older people: main outcome of the ASPREE-XT observational studyRaj C Shah, Joanne Ryan, Katherine L Webb, et al.
Age and Ageing|September 18, 2025
The association of retinal vessel calibre, white matter hyperintensities and cognitive decline in community-dwelling older adultsCatherine Robb, Amy Brodtmann, Robyn L Woods, et al.
Sleep|September 20, 2024
Obstructive sleep apnea and cerebral small vessel disease in community-based older people: an aspirin in reducing events in the elderly imaging substudyStephanie A Ward, Elsdon Storey, Matthew T Naughton, et al.
The Lancet. Diabetes & Endocrinology|May 11, 2026
A comparison of the effects of tirzepatide and dulaglutide on major kidney events in people with type 2 diabetes: pre-specified exploratory analyses of the SURPASS-CVOT trialSophia Zoungas, David D'Alessio, Imre Pavo, et al.
Clinical Trials (London, England)|July 6, 2025
From the ASPREE investigators: Response to Wittes et alJohn J McNeil, Andrew M Tonkin, Anne B Newman, et al.
JAMA Cardiology|October 15, 2025
Clonal Hematopoiesis and Cardiovascular Disease and Bleeding Risk and the Effectiveness of AspirinZoe K McQuilten, Le T P Thao, Alexander G Bick, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 28, 2020
Effect of Aspirin on Activities of Daily Living Disability in Community-Dwelling Older AdultsRobyn L Woods, Sara Espinoza, Le T P Thao, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 10, 2021
The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly StudySara E Espinoza, Robyn L Woods, A R M Saifuddin Ekram, et al.
JAMA Ophthalmology|May 23, 2024
Effect of Low-Dose Aspirin on the Course of Age-Related Macular Degeneration: A Secondary Analysis of the ASPREE Randomized Clinical TrialLiubov D Robman, Rory Wolfe, Robyn L Woods, et al.
Neurology|October 25, 2023
Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort StudyZhen Zhou, Joanne Ryan, Andrew M Tonkin, et al.
Pageof 43